Who is the CEO of GRAIL, Inc. Common Stock?

The CEO of GRAIL, Inc. Common Stock is Robert P. Ragusa.

What industry does GRAIL, Inc. Common Stock belong to?

GRAIL, Inc. Common Stock operates in the Medical - Diagnostics & Research industry within the Healthcare sector.

Where is GRAIL, Inc. Common Stock headquartered?

GRAIL, Inc. Common Stock is headquartered at 1525 O’Brien Drive, Menlo Park, CA, 94025, US.

How many employees does GRAIL, Inc. Common Stock have?

The total number of employees at GRAIL, Inc. Common Stock is disclosed periodically in the company's annual financial reports.

GRAIL, Inc. Common Stock

GRALV•NASDAQ

Healthcare

Medical - Diagnostics & Research

$18.63

$1.41(8.19%)

GRAIL, Inc. Common Stock (GRALV) Company Profile & Overview

Explore GRAIL, Inc. Common Stock’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

GRAIL, Inc. Common Stock (GRALV) Company Profile & Overview

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.

SectorHealthcare

IndustryMedical - Diagnostics & Research

CEORobert P. Ragusa

Contact Information

https://grail.com

833-694-2553

1525 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

CountryUS

Frequently Asked Questions

;